NiteHush Pro is rapidly emerging as the go-to solution for those struggling with persistent snoring and dangerous sleep apnea ...
The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...
2d
Investor's Business Daily on MSNNovartis Has A Slight Edge On Travere — Why Analysts Aren't WorriedNovartis stock popped Thursday — prompting Travere Therapeutics to slide — after winning FDA approval for a kidney disease treatment.
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s ...
The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...
The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results